Public health messaging and harm reduction in the time of COVID-19

. 2020 May;7(5):390-391.

doi: 10.1016/S2215-0366(20)30144-9.

Affiliations

¹ British Columbia Centre on Substance Use, Vancouver, BC V6Z 2A9, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; HIV/STI Surveillance Research Centre, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
² British Columbia Centre on Substance Use, Vancouver, BC V6Z 2A9, Canada; School of Nursing, University of British Columbia, Vancouver, BC, Canada.
³ British Columbia Centre on Substance Use, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada. Electronic address: bccsu-tk@bccsu.ubc.ca.

Mohammad Karamouzian et al. Lancet Psychiatry. 2020 May.

. 2020 May;7(5):390-391.

doi: 10.1016/S2215-0366(20)30144-9.

¹ British Columbia Centre on Substance Use, Vancouver, BC V6Z 2A9, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; HIV/STI Surveillance Research Centre, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
² British Columbia Centre on Substance Use, Vancouver, BC V6Z 2A9, Canada; School of Nursing, University of British Columbia, Vancouver, BC, Canada.
³ British Columbia Centre on Substance Use, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada. Electronic address: bccsu-tk@bccsu.ubc.ca.

No abstract available

References

1. WHO WHO Director-General's opening remarks at the media briefing on COVID-19. March 11, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
1. Karamouzian M, Papamihali K, Graham B. Known fentanyl use among clients of harm reduction sites in British Columbia, Canada. Int J Drug Policy. 2020;77 - PubMed
1. Proctor J. What is a ‘safe supply’ of drugs and how would it work? CBC. Sept 13, 2019. https://www.cbc.ca/news/canada/british-columbia/safe-supply-drugs-opioid...
1. Ahamad K, Compton M, Dolman C. British Columbia Centre on Substance Use; British Columbia: 2019. Guidance for injectable opioid agonist treatment for opioid use disorder.
1. Klimas J, Gorfinkel L, Giacomuzzi SM. Slow release oral morphine versus methadone for the treatment of opioid use disorder. BMJ Open. 2019;9 - PMC - PubMed